PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

New data for engineering immune cells shows early promise in solid tumors

2013-12-20
(Press-News.org) Contact information: Jeremy Moore
jeremy.moore@aacr.org
215-446-7109
American Association for Cancer Research
New data for engineering immune cells shows early promise in solid tumors PHILADELPHIA — Engineered immune cells, called CARTmeso cells, designed to direct antitumor immune responses toward tumors that carry a protein called mesothelin, showed antitumor activity in two patients with advanced cancers that had not responded to prior treatments, according to a study published in Cancer Immunology Research, a journal of the American Association for Cancer Research.

Chimeric antigen receptor T cells (CAR T cells) are a form of personalized cell therapy that uses immune cells called T cells from patients. After T cells are harvested from a patient, they are engineered to bear a molecule that allows them to attach to a specific protein carried by the patient's cancer cells and to be triggered to kill the cancer cells when they do so. CAR T cells have shown early promising results for patients with some types of leukemia and lymphoma; however, they have not been very successful for solid cancers, one of the major issues being toxicity. Because normal cells express the CAR T cell target protein, albeit at lower levels than cancer cells, the engineered T cells recognize and attack the normal cells as well the cancer cells, causing off-target toxicity.

"So far, researchers have been permanently modifying T cells by using a variety of methods, including using viruses," said Carl H. June, M.D., a professor of pathology and laboratory medicine in the Perelman School of Medicine at the University of Pennsylvania and director of translational research in the university's Abramson Cancer Center.

"We engineered T cells to express a CAR for about three days, after which the mRNA is metabolized rapidly by the system, so the T cells basically revert to what they were before in the patient," explained June. "These T cells recognize a protein called mesothelin present in many tumors, including mesothelioma and pancreatic cancers, hence we named them CARTmeso cells. Our strategy is to give multiple infusions of CARTmeso cells to the patient, and if there is toxicity, we could abort the toxicity just by stopping the infusions, because the mRNA-based CARs rapidly revert to normal T cells."

"We found that the temporary CARs we engineered are safe, with no significant on-target, off-tumor toxicity," June added. "We have evidence of antitumor effects in two patients whose advanced tumors failed previous therapies. These results, albeit preliminary, are very promising."

June and colleagues recruited two patients, ages 75 and 81 years, to a phase I clinical trial. One patient had advanced mesothelioma, and the other patient had metastatic pancreatic cancer that progressed after failing first-line therapy. The objective of this trial was to evaluate the manufacturing feasibility and safety of the mRNA-based CARTmeso cells. The researchers isolated T cells from the patients, reproduced them in large numbers in the laboratory, and engineered them to recognize mesothelin on tumor cells, using a biological material called mRNA. After ensuring viability and specificity of the engineered cells, the researchers infused the patients' modified T cells back into their bodies.

After receiving three infusions of CARTmeso cells, the patient with mesothelioma showed stable disease, as evaluated by imaging. The patient with pancreatic cancer received eight infusions of CARTmeso cells, and fluid collected from his abdomen showed a 40 percent decrease in the number of tumor cells that expressed mesothelin. The researchers evaluated additional tumor markers and confirmed antitumor activity.

"We found that these CARTmeso cells not only have antitumor activity, but also act like a vaccine, and trigger a response against the patient's own tumor," said June. "This new form of CAR therapy provides a new tool to evaluate CAR therapies for solid cancers."

Adverse events observed during the trial include an anaphylactic reaction and an intestinal obstruction.

### This study was funded by grants from the National Institutes of Health, The Prevor Family Fund for Immunotherapy Cancer Research, and The Lustgarten Foundation. June and co-investigator B. Levine have commercial research support and ownership interest (including patents) from Novartis. June, Levine, and co-investigators Y. Zhao, and M. Kalos have financial interests due to intellectual property and patents in the field of cell and gene therapy.

Follow the AACR on Twitter: @AACR Follow the AACR on Facebook: http://www.facebook.com/aacr.org

About the American Association for Cancer Research Founded in 1907, the American Association for Cancer Research (AACR) is the world's oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 34,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in more than 90 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 20 conferences and educational workshops, the largest of which is the AACR Annual Meeting with more than 18,000 attendees. In addition, the AACR publishes eight peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the scientific partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit http://www.AACR.org.

To interview Carl June, contact Holly Auer at holly.auer@uphs.upenn.edu or 215-200-2313. For other inquiries, contact Jeremy Moore at jeremy.moore@aacr.org or 215-446-7109.


ELSE PRESS RELEASES FROM THIS DATE:

Sugar cane fires in Louisiana

2013-12-20
Sugar cane fires in Louisiana According to KATC Channel 3 in Lafayette, LA on December 17, 2013 , thick plumes of smoke are visible for miles around Acadiana (the mostly French region of Louisiana in the southern part of the state). They aren't major fires, but instead ...

Parasitic DNA proliferates in aging tissues

2013-12-20
Parasitic DNA proliferates in aging tissues The genomes of organisms from humans to corn are replete with "parasitic" strands of DNA that, when not suppressed, copy themselves and spread throughout the genome, potentially affecting health. Earlier this year Brown University researchers ...

Common disorders: It's not the genes themselves, but how they are controlled

2013-12-20
Common disorders: It's not the genes themselves, but how they are controlled Case Western Reserve identifies multiple DNA changes cause disease, offering new drug targets Many rare disorders are caused by gene mutation, like sickle cell anemia. Yet ...

Want to stop smoking? See a specialist!

2013-12-20
Want to stop smoking? See a specialist! Smokers in England who want to stop smoking are three times more likely to succeed if they see a trained advisor than if they try by themselves, according to a new study published online today in the medical journal Addiction. Worryingly, ...

Gene transfer gone wild reveals driving force behind mitochondrial sex

2013-12-20
Gene transfer gone wild reveals driving force behind mitochondrial sex Report largest example of horizontal gene transfer in any organism Pioneering research led by Indiana University has identified genes from a number of plant species, including the entire mitochondrial ...

Science's top 10 breakthroughs of 2013

2013-12-20
Science's top 10 breakthroughs of 2013 Journal celebrates recent success with cancer immunotherapy and more This news release is available in Spanish, French, Arabic, Japanese and Chinese. The cancer research community experienced ...

The origin of flowers: DNA of storied plant provides insight into the evolution of flowering plants

2013-12-20
The origin of flowers: DNA of storied plant provides insight into the evolution of flowering plants The newly sequenced genome of the Amborella plant addresses Darwin's "abominable mystery" -- the question of why flowers suddenly proliferated on Earth millions of years ...

Cocaine, meth response differ between 2 substrains of 'Black 6' laboratory mouse

2013-12-20
Cocaine, meth response differ between 2 substrains of 'Black 6' laboratory mouse Researchers including Jackson Laboratory Professor Gary Churchill, Ph.D., have found a single nucleotide polymorphism (SNP) difference in cocaine and methamphetamine response between ...

Researchers generate kidney tubular cells from stem cells

2013-12-20
Researchers generate kidney tubular cells from stem cells Advance could allow regenerative medicine to replace dialysis or transplantation for treating kidney failure Washington, DC (December 19, 2013) — Researchers have successfully coaxed stem cells to become kidney ...

Stowers researchers announce first genetic model of a human jaw fusion defect known as syngnathia

2013-12-20
Stowers researchers announce first genetic model of a human jaw fusion defect known as syngnathia KANSAS CITY, MO—The face you critiqued in the mirror this morning was sculpted before you were born by a transient population of cells called neural crest ...

LAST 30 PRESS RELEASES:

Older teens who start vaping post-high school risk rapid progress to frequent use

Corpse flowers are threatened by spotty recordkeeping

Riding the AI wave toward rapid, precise ocean simulations

Are lifetimes of big appliances really shrinking?

Pink skies

Monkeys are world’s best yodellers - new research

Key differences between visual- and memory-led Alzheimer’s discovered

% weight loss targets in obesity management – is this the wrong objective?

An app can change how you see yourself at work

NYC speed cameras take six months to change driver behavior, effects vary by neighborhood, new study reveals

New research shows that propaganda is on the rise in China

Even the richest Americans face shorter lifespans than their European counterparts, study finds

Novel genes linked to rare childhood diarrhea

New computer model reveals how Bronze Age Scandinavians could have crossed the sea

Novel point-of-care technology delivers accurate HIV results in minutes

Researchers reveal key brain differences to explain why Ritalin helps improve focus in some more than others

Study finds nearly five-fold increase in hospitalizations for common cause of stroke

Study reveals how alcohol abuse damages cognition

Medicinal cannabis is linked to long-term benefits in health-related quality of life

Microplastics detected in cat placentas and fetuses during early pregnancy

Ancient amphibians as big as alligators died in mass mortality event in Triassic Wyoming

Scientists uncover the first clear evidence of air sacs in the fossilized bones of alvarezsaurian dinosaurs: the "hollow bones" which help modern day birds to fly

Alcohol makes male flies sexy

TB patients globally often incur "catastrophic costs" of up to $11,329 USD, despite many countries offering free treatment, with predominant drivers of cost being hospitalization and loss of income

Study links teen girls’ screen time to sleep disruptions and depression

Scientists unveil starfish-inspired wearable tech for heart monitoring

Footprints reveal prehistoric Scottish lagoons were stomping grounds for giant Jurassic dinosaurs

AI effectively predicts dementia risk in American Indian/Alaska Native elders

First guideline on newborn screening for cystic fibrosis calls for changes in practice to improve outcomes

Existing international law can help secure peace and security in outer space, study shows

[Press-News.org] New data for engineering immune cells shows early promise in solid tumors